Cannabinoid Innovation

RESEARCHED & DEVELOPED IN ISRAEL

Crafted in the UK to EU Standards

Partnering with Leading Institutions

CUTTING-EDGE CANNABIS PRODUCTS

Supported by Clinical Research

ISRAELI RESEARCH

Products Made in UK

CANNABIS PRODUCTS

Clinical Research

EXPORTING ISRAELI CANNABIS INNOVATION

CIITECH partners with leading institutions and companies in Israel and the UK to leverage cutting-edge cannabis science and clinical research. Our mission is to craft unique cannabis therapeutic products that can help a wide range of indications.

Our vision is to contribute to the future where people are free to choose between physician prescribed cannabinoid-based pharmaceuticals or nutraceutical & wellness products on recommendation & anecdotal evidence.

WHAT WE DO

SCIENTIFIC RESEARCH

CIITECH has partnered with the leading Israeli academic institution for cannabinoid research.

Good product develops by understanding the profile and behaviour of the hundreds of molecules found in the cannabis plant. Through science, we gain clarity to advance towards effective products.

NOVEL FORMULATIONS

CIITECH’s partners include leading Israeli scientists and pharmaceutical experts.

Together with our UK production partner, we are creating new and novel cannabinoid formulations for the wellness market with the precision and consistency of clinically validated medicine.

DELIVERY MECHANISMS

CIITECH identifies innovative & optimal delivery mechanisms for cannabinoid bioavailability.

We have partnered with an Israeli based medical cannabis biotech company to bring the UK and Europe a high-quality, safe and reliable medical grade vaporizer, suitable for CBD and CBG.

RESEARCH & FOCUS

CIITECH is investigating a wide spectrum of minor cannabinoids and combination profiles for multiple application and delivery mechanisms. Our initial studies will focus on the use of cannabigerol (CBG) as primary molecule.

Whilst potential medical applications are wide ranging, our areas of focus are; dermatalogical, digestive and neurological disorders.

HEALTHCARE

ADHD & Migraine together with related neurological conditions

Obesity & Diabetes together with related metabolism disorders.

Psoriasis & Eczema together with related dermatological conditions

CANNABINOIDS

Cannabigerol. CBG is a non-psychoactive cannabinoid. CBG is the genetic precursor molecule to all subsequent cannabinoids (THC, CBD, +).

Combinations. Testing the entourage effects of combining cannabinoids, terpenoids and other known molecules.

CONTACT US

CIITECH leverages Israeli excellence in research, medical advancements, and cannabis innovation to provide the UK and Europe with the know-how to produce and market therapeutic cannabis-based products. Get in touch with us – we would love to hear from you!

ISRAEL: 00972 (0)54 808 6559

UK: 0044 (0)203 734 7764